GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. is one of the world’s leading medical technology, pharmaceutical diagnostics, and digital healthcare companies. Originally established as part of General Electric’s healthcare division and operating as an independent publicly traded company since 2023, GE HealthCare is headquartered in Chicago, Illinois, United States. The company serves healthcare providers in more than 160 countries through a comprehensive portfolio of imaging systems, patient monitoring solutions, ultrasound equipment, healthcare IT platforms, and precision care technologies.

GE HealthCare is internationally recognized for its expertise in magnetic resonance imaging (MRI), computed tomography (CT), molecular imaging (PET/SPECT), X-ray systems, ultrasound, anesthesia delivery systems, maternal and infant care, patient monitoring, and image-guided therapy. The company also develops AI-powered clinical decision support tools, cloud-based healthcare platforms, and pharmaceutical diagnostic solutions that improve workflow efficiency and diagnostic accuracy.

With major research and manufacturing facilities across North America, Europe, and Asia, GE HealthCare invests heavily in artificial intelligence, digital imaging, precision medicine, and connected healthcare ecosystems. Its products comply with global regulatory requirements established by the US FDA, European MDR, Health Canada, PMDA (Japan), and numerous international health authorities.

Through continuous technological innovation and partnerships with hospitals, universities, and research organizations, GE HealthCare remains one of the world’s most influential providers of advanced medical technology and diagnostic imaging solutions.